Stylianos Lefkopoulos (he/him)
@slefkopoulos.bsky.social did:plc:mz4nog7rtfpvxjkjk567dsp7
Senior Editor at @natcellbio.nature.com: #stemcells & #embryo development #disease | proud scientist | 🏳️🌈 gender fluid, antisexist, liberal | 🍫 📚 🐶 🧑🍳 🌱 |📍Berlin | views are his own | call him Stelios
Bei Bluesky seit
- Follower
- 3.287
- Folgt
- 361
- Posts
- 231
- Tage in Ranglisten
- 0
Zusammenfassung
Stylianos Lefkopoulos (he/him) (@slefkopoulos.bsky.social) ist seit 14 November 2024 auf Bluesky. Das Konto hat 3.287 Follower, folgt 361 Konten und hat 231 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
It's already been 20 years since Kazutoshi Takahashi and Shinya Yamanaka published their landmark paper on iPSCs in Cell. Amazing how a single publication could spark an entire field! #iPSCell buff.ly/sRzPzBr
Post anzeigenThis is a very cool paper for those of us studying pregnancy and cancer. Of course, implantation needs to be a dialogue between the decidua and the blastocyst, but now we know some of the sentences they use to talk to each other.....
Post anzeigenIt was a brilliant opportunity to be able to comment on this latest assembloid story ! Exciting to see the field moving forward !
Post anzeigenMissed highlighting my choice last week in @science.org Elevated contractility drives implantation failure in mouse embryos from aged females www.nature.com/articles/s41...
Post anzeigenThe transformative concept of cellular reprogramming is now being applied for in vivo cancer immunotherapy. How might the next 20 years expand reprogramming approaches within the tumor microenvironment? Exciting times ahead! #iPSC #CellularReprogramming #CancerImmunotherapy
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
